FDA tentatively approves Merck's copycat of Sanofi's Lantus
July 20, 2017 at 12:55 PM EDT
July 20 (Reuters) - Merck and Co Inc said on Thursday the U.S. Food and Drug Administration (FDA) tentatively approved its biosimilar version of French drugmaker Sanofi SA's blockbuster diabetes treatment, Lantus.
